» Articles » PMID: 35877777

Astragalus Polysaccharides and Astragaloside IV Alleviate Inflammation in Bovine Mammary Epithelial Cells by Regulating Wnt/β-catenin Signaling Pathway

Overview
Journal PLoS One
Date 2022 Jul 25
PMID 35877777
Authors
Affiliations
Soon will be listed here.
Abstract

The Wnt/β-catenin signaling regulates cell renewal and repair and is closely associated with inflammation. Astragalus polysaccharides (APS) and astragaloside IV (AS-IV), which are the main active substances extracted from Radix Astragali, protect cells by regulating Wnt signaling in cells, exerting antiinflammatory, antioxidant, and antistress effects. However, the mechanisms by which APS and AS-IV interact with Wnt signaling to achieve their therapeutic effects in bovine mammary epithelial cells (BMECs) are not understood. In this study, we used lipopolysaccharide (LPS)-stimulated BMECs as an in vitro model of inflammation to investigate the effects of APS and AS-IV on Wnt signaling in inflamed BMECs. Drug concentrations were screened using the CCK-8 method, the effect on protein expression was analyzed using immunoblotting, the effect on inflammatory factors using enzyme-linked immunosorbent assay, and the effect on oxidative factors using enzyme labeling and flow cytometry. LPS activated the expression of inflammatory and oxidative factors in cells and inhibited Wnt/β-catenin signaling. APS and AS-IV antagonized the inhibitory effect of LPS, protecting BMECs. They inhibited the expression of the IL-6, IL-8, and TNF-α inflammatory factors, and that of the MDA oxidative factor, and activated Wnt signaling in LPS-stimulated BMECs. Silencing of β-catenin abolished the protective effect of APS and AS-IV against LPS-stimulated BMECs. Thus, APS and AS-IV mediate protective effects in inflammatory BMECs model through activation of the Wnt signaling pathway. Wnt signaling pathway is one of the targets of the inhibitory effects of APS and AS-IV on inflammation.

Citing Articles

Astragali radix (Huangqi): a time-honored nourishing herbal medicine.

Zhang Y, Chen Z, Chen L, Dong Q, Yang D, Zhang Q Chin Med. 2024; 19(1):119.

PMID: 39215362 PMC: 11363671. DOI: 10.1186/s13020-024-00977-z.


Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer.

Zhang Y, Kang Q, He L, Chan K, Gu H, Xue W Chin Med. 2024; 19(1):117.

PMID: 39210410 PMC: 11360867. DOI: 10.1186/s13020-024-00978-y.


Research state of the herbal medicine Huangqi (Radix Astragali): A global and bibliometric study.

Chen Y, Xie M, Zhou S, Liu F Medicine (Baltimore). 2024; 103(8):e37277.

PMID: 38394541 PMC: 11309597. DOI: 10.1097/MD.0000000000037277.


The Large Molecular Weight Polysaccharide from Wild Cordyceps and Its Antitumor Activity on H22 Tumor-Bearing Mice.

Tan L, Liu S, Li X, He J, He L, Li Y Molecules. 2023; 28(8).

PMID: 37110586 PMC: 10141569. DOI: 10.3390/molecules28083351.

References
1.
Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, Nakazawa M . Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol. 2010; 37(5):1095-103. DOI: 10.3892/ijo_00000761. View

2.
Kim J, Yeo S, Shin D, Bae Y, Lee J, Chin B . Glycogen synthase kinase 3beta and beta-catenin pathway is involved in toll-like receptor 4-mediated NADPH oxidase 1 expression in macrophages. FEBS J. 2010; 277(13):2830-7. DOI: 10.1111/j.1742-4658.2010.07700.x. View

3.
Jia F, Zhang X, Ma W, Li X, Zhou X . Cytotoxicity and anti-inflammatory effect of a novel diminazene aceturate derivative in bovine mammary epithelial cells. Res Vet Sci. 2021; 137:102-110. DOI: 10.1016/j.rvsc.2021.04.025. View

4.
Sen M, Chamorro M, Reifert J, Corr M, Carson D . Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum. 2001; 44(4):772-81. DOI: 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.0.CO;2-L. View

5.
Li F, Li X, Wang Y, Xiao X, Xu R, Chen J . Astragaloside IV Downregulates β-Catenin in Rat Keratinocytes to Counter LiCl-Induced Inhibition of Proliferation and Migration. Evid Based Complement Alternat Med. 2012; 2012:956107. PMC: 3368212. DOI: 10.1155/2012/956107. View